|
1
|
Shin W, Won YJ, Yoo CW, Lim J and Lim MC:
Incidence trends for epithelial peritoneal, ovarian, and fallopian
tube cancer during 1999–2016: A retrospective study based on the
Korean National Cancer Incidence Database. J Gynecol Oncol.
31:e562020. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Guttman M, Donaghey J, Carey BW, Garber M,
Grenier JK, Munson G, Young G, Lucas AB, Ach R, Bruhn L, et al:
lincRNAs act in the circuitry controlling pluripotency and
differentiation. Nature. 477:295–300. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Kim HJ, Eoh KJ, Kim LK, Nam EJ, Yoon SO,
Kim KH, Lee JK, Kim SW and Kim YT: The long noncoding RNA HOXA11
antisense induces tumor progression and stemness maintenance in
cervical cancer. Oncotarget. 7:83001–83016. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Eoh KJ, Paek J, Kim SW, Kim HJ, Lee HY,
Lee SK and Kim YT: Long non-coding RNA, steroid receptor RNA
activator (SRA), induces tumor proliferation and invasion through
the NOTCH pathway in cervical cancer cell lines. Oncol Rep.
38:3481–3488. 2017.PubMed/NCBI
|
|
5
|
Arumugam T, Ramachandran V, Fournier KF,
Wang H, Marquis L, Abbruzzese JL, Gallick GE, Logsdon CD, McConkey
DJ and Choi W: Epithelial to mesenchymal transition contributes to
drug resistance in pancreatic cancer. Cancer Res. 69:5820–5828.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Fischer KR, Durrans A, Lee S, Sheng J, Li
F, Wong ST, Choi H, El Rayes T, Ryu S, Troeger J, et al:
Epithelial-to-mesenchymal transition is not required for lung
metastasis but contributes to chemoresistance. Nature. 527:472–476.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Wu F, Zhang C, Cai J, Yang F, Liang T, Yan
X, Wang H, Wang W, Chen J and Jiang T: Upregulation of long
noncoding RNA HOXA-AS3 promotes tumor progression and predicts poor
prognosis in glioma. Oncotarget. 8:53110–53123. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zhang H, Liu Y, Yan L, Zhang M, Yu X, Du
W, Wang S, Li Q, Chen H, Zhang Y, et al: Increased levels of the
long noncoding RNA, HOXA-AS3, promote proliferation of A549 cells.
Cell Death Dis. 9:7072018. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Lin S, Zhang R, An X, Li Z, Fang C, Pan B,
Chen W, Xu G and Han W: LncRNA HOXA-AS3 confers cisplatin
resistance by interacting with HOXA3 in non-small-cell lung
carcinoma cells. Oncogenesis. 8:602019. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Yim GW, Lee DW, Kim JI and Kim YT: Long
Non-coding RNA LOC285194 promotes epithelial ovarian cancer
progression via the apoptosis signaling pathway. In Vivo.
36:121–131. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Eoh KJ, Kim HJ, Lee JW, Kim LK, Park SA,
Kim HS, Kim YT and Koo PJ: E2F8 induces cell proliferation and
invasion through the Epithelial-mesenchymal transition and notch
signaling pathways in ovarian cancer. Int J Mol Sci. 21:58132020.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Gupta RA, Shah N, Wang KC, Kim J, Horlings
HM, Wong DJ, Tsai MC, Hung T, Argani P, Rinn JL, et al: Long
non-coding RNA HOTAIR reprograms chromatin state to promote cancer
metastasis. Nature. 464:1071–1076. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Kim HJ, Lee DW, Yim GW, Nam EJ, Kim S, Kim
SW and Kim YT: Long non-coding RNA HOTAIR is associated with human
cervical cancer progression. Int J Oncol. 46:521–530. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Sun H, Chen J, Qian W, Kang J, Wang J,
Jiang L, Qiao L, Chen W and Zhang J: Integrated long non-coding RNA
analyses identify novel regulators of epithelial-mesenchymal
transition in the mouse model of pulmonary fibrosis. J Cell Mol
Med. 20:1234–1246. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Sun Z, Yang S, Zhou Q, Wang G, Song J, Li
Z, Zhang Z, Xu J, Xia K and Chang Y: Emerging role of
exosome-derived long non-coding RNAs in tumor microenvironment. Mol
Cancer. 17:822018. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Marcucci F, Stassi G and De Maria R:
Epithelial-mesenchymal transition: A new target in anticancer drug
discovery. Nat Rev Drug Discov. 15:311–325. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Tang Y, Cheung BB, Atmadibrata B, Marshall
GM, Dinger ME, Liu PY and Liu T: The regulatory role of long
noncoding RNAs in cancer. Cancer Lett. 391:12–19. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Ohana P, Bibi O, Matouk I, Levy C, Birman
T, Ariel I, Schneider T, Ayesh S, Giladi H, Laster M, et al: Use of
H19 regulatory sequences for targeted gene therapy in cancer. Int J
Cancer. 98:645–650. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Mizrahi A, Czerniak A, Levy T, Amiur S,
Gallula J, Matouk I, Abu-Lail R, Sorin V, Birman T, de Groot N, et
al: Development of targeted therapy for ovarian cancer mediated by
a plasmid expressing diphtheria toxin under the control of H19
regulatory sequences. J Transl Med. 7:692009. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Gofrit ON, Benjamin S, Halachmi S,
Leibovitch I, Dotan Z, Lamm DL, Ehrlich N, Yutkin V, Ben-Am M and
Hochberg A: DNA based therapy with diphtheria toxin-A BC-819: A
phase 2b marker lesion trial in patients with intermediate risk
nonmuscle invasive bladder cancer. J Urol. 191:1697–1702. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Hanna N, Ohana P, Konikoff FM, Leichtmann
G, Hubert A, Appelbaum L, Kopelman Y, Czerniak A and Hochberg A:
Phase 1/2a, dose-escalation, safety, pharmacokinetic and
preliminary efficacy study of intratumoral administration of BC-819
in patients with unresectable pancreatic cancer. Cancer Gene Ther.
19:374–381. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Hasenpusch G, Pfeifer C, Aneja MK, Wagner
K, Reinhardt D, Gilon M, Ohana P, Hochberg A and Rudolph C:
Aerosolized BC-819 inhibits primary but not secondary lung cancer
growth. PLoS One. 6:e207602011. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Lavie O, Edelman D, Levy T, Fishman A,
Hubert A, Segev Y, Raveh E, Gilon M and Hochberg A: A phase 1/2a,
dose-escalation, safety, pharmacokinetic, and preliminary efficacy
study of intraperitoneal administration of BC-819 (H19-DTA) in
subjects with recurrent ovarian/peritoneal cancer. Arch Gynecol
Obstet. 295:751–761. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Sidi AA, Ohana P, Benjamin S, Shalev M,
Ransom JH, Lamm D, Hochberg A and Leibovitch I: Phase I/II marker
lesion study of intravesical BC-819 DNA plasmid in H19 over
expressing superficial bladder cancer refractory to bacillus
Calmette-Guerin. J Urol. 180:2379–2383. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Smaldone MC and Davies BJ: BC-819, a
plasmid comprising the H19 gene regulatory sequences and diphtheria
toxin A, for the potential targeted therapy of cancers. Curr Opin
Mol Ther. 12:607–616. 2010.PubMed/NCBI
|
|
27
|
Zhu XX, Yan YW, Chen D, Ai CZ, Lu X, Xu
SS, Jiang S, Zhong GS, Chen DB and Jiang YZ: Long non-coding RNA
HoxA-AS3 interacts with EZH2 to regulate lineage commitment of
mesenchymal stem cells. Oncotarget. 7:63561–63570. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Chen YG, Satpathy AT and Chang HY: Gene
regulation in the immune system by long noncoding RNAs. Nat
Immunol. 18:962–972. 2017. View
Article : Google Scholar : PubMed/NCBI
|
|
29
|
Jiang C, Li X, Zhao H and Liu H: Long
non-coding RNAs: Potential new biomarkers for predicting tumor
invasion and metastasis. Mol Cancer. 15:622016. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Peng WX, Koirala P and Mo YY:
LncRNA-mediated regulation of cell signaling in cancer. Oncogene.
36:5661–5667. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Kyba M: Modulating the malignancy of Hox
proteins. Blood. 129:269–270. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Monterisi S, Lo Riso P, Russo K, Bertalot
G, Vecchi M, Testa G, Di Fiore PP and Bianchi F: HOXB7
overexpression in lung cancer is a hallmark of acquired stem-like
phenotype. Oncogene. 37:3575–3588. 2018. View Article : Google Scholar : PubMed/NCBI
|
